BioMap
Palo Alto
About BioMap
Founded in 2020 by Robin Li and Wei Liu, BioMap is a disruptive life science AI company responsible for building xTrimo, the first and largest protein-centric large language model platform. Their technology allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. Supported by an international, cross-functional team of over 300 experts, BioMap is solving critical, protein-related drug development problems and charting a course to radically improve patients’ lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $100.0M
- Last round: Series Unknown (Jun 2024)
- Website: biomap.com
- Phone: +91 8105645796 / 8482 234911
Industries & Categories
Artificial Intelligence (AI), Generative AI, Life Science, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/biomap-3273 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.